Toll-like receptor 4: A potential therapeutic target for multiple human diseases

被引：23
|
作者：
Wei, Jinrui [1 ,2 ,3 ]
Zhang, Yan [1 ,2 ,3 ]
Li, Haopeng [1 ,2 ,3 ]
Wang, Fuquan [1 ,2 ,3 ]
Yao, Shanglong [1 ,2 ,3 ,4 ]
机构：
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Anesthesiol, Wuhan 430022, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Inst Anesthesia & Crit Care Med, Tongji Med Coll, Wuhan 430022, Peoples R China
[3] Huazhong Univ Sci & Technol, Key Lab Anesthesiol & Resuscitat, Minist Educ, Hongshan, Peoples R China
[4] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Anesthesiol, 1277 Jiefang Ave, Wuhan 430022, Peoples R China
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2023年 / 166卷
关键词：
Immune response; Toll -like receptor 4; Cardiovascular; Neoplastic; Inflammatory; NF-KAPPA-B; ESOPHAGEAL CANCER-CELLS; TRAUMATIC BRAIN-INJURY; NLRP3; INFLAMMASOME; REGULATORY FACTOR-3; ADHESION MOLECULES; SIGNALING PATHWAYS; ACTIVATION; TLR4; LIPOPOLYSACCHARIDE;
D O I：
10.1016/j.biopha.2023.115338
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The immune response plays a pivotal role in the pathogenesis of diseases. Toll-like receptor 4 (TLR4), as an intrinsic immune receptor, exhibits widespread in vivo expression and its dysregulation significantly contributes to the onset of various diseases, encompassing cardiovascular disorders, neoplastic conditions, and inflammatory ailments. This comprehensive review centers on elucidating the architectural and distributive characteristics of TLR4, its conventional signaling pathways, and its mode of action in diverse disease contexts. Ultimately, this review aims to propose novel avenues and therapeutic targets for clinical intervention.
引用
收藏
页数：9
相关论文
共 50 条
  • [21] Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic target
    Greulich, Benjamin M.
    Plotnik, Joshua P.
    Jerde, Travis J.
    Hollenhorst, Peter C.
    NAR CANCER, 2021, 3 (01): : 1 - 11
  • [22] Toll-like receptor signalling as a cannabinoid target
    Sun, Melody Cui
    Otalora-Alcaraz, Almudena
    Prenderville, Jack A.
    Downer, Eric J.
    BIOCHEMICAL PHARMACOLOGY, 2024, 222
  • [23] Toll-Like Receptor 3 in Cardiovascular Diseases
    Zhuang, Chunying
    Chen, Riken
    Zheng, Zhenzhen
    Lu, Jianmin
    Hong, Cheng
    HEART LUNG AND CIRCULATION, 2022, 31 (07) : E93 - E109
  • [24] Toll-Like Receptor Pathways in Autoimmune Diseases
    Chen, Ji-Qing
    Szodoray, Peter
    Zeher, Margit
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2016, 50 (01) : 1 - 17
  • [25] Toll-like receptor expression during inflammatory processes in human diseases
    Dhakad, Prashant K.
    Mishra, Raghav
    Mishra, Isha
    RHEUMATOLOGY & AUTOIMMUNITY, 2025, 5 (01): : 1 - 14
  • [26] Toll-like receptor 1 inhibits Toll-like receptor 4 signaling in endothelial cells
    Spitzer, JH
    Visintin, A
    Mazzoni, A
    Kennedy, MN
    Segal, DM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (04) : 1182 - 1187
  • [27] Human melanocytes express functional Toll-like receptor 4
    Ahn, Joo Hee
    Park, Tae Jun
    Jin, Sun Hee
    Kang, Hee Young
    EXPERIMENTAL DERMATOLOGY, 2008, 17 (05) : 412 - 417
  • [28] Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways
    Roy, Anjali
    Srivastava, Mansi
    Saqib, Uzma
    Liu, Dongfang
    Faisal, Syed M.
    Sugathan, Subi
    Bishnoi, Suman
    Baig, Mirza S.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 40 : 79 - 89
  • [29] Expression of Toll-like Receptor 2 and Toll-like Receptor 4 in Tuberculous Pleural Effusion
    Lin, Yingzhong
    Feng, Tingmei
    Lan, Jiao
    Chen, Chunxia
    Qin, Zhiqiang
    Wu, Yanbin
    Shi, Huanzhong
    Ye, Jianbo
    Wei, Caizhou
    Wang, Wu
    Huang, Luying
    MEDICINAL CHEMISTRY, 2017, 13 (06) : 569 - 576
  • [30] Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
    Farooq, Mariya
    Batool, Maria
    Kim, Moon Suk
    Choi, Sangdun
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 09
12345